Research shows that even low levels of air pollution can contribute to severe respiratory infections in adults. Study: Long-term exposure to air pollution and lower respiratory infections in a ...

and viral induced acute respiratory distress syndrome, today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present at the upcoming virtual ...

It is important to alert clinicians that although there is a paucity of evidence on the best strategy to adjust PEEP in patients, the use of electrical impedance tomography seems promising. The work ...

4 Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, Amsterdam, The Netherlands Rationale We hypothesised that patients with acute respiratory distress syndrome (ARDS) can ...

In preparation for the Spring Undergraduate Research Conference abstract submission deadline on Feb. 27, this seminar will discuss how to write an abstract with common components, how to submit it for ...

Here, I will describe my group’s recent work using controlled human infection and vaccination studies to investigate immunity in the respiratory tract associated with protection from infection as well ...

Breathe in. In that one simple motion, your diaphragm tightened up and moved down. This made your chest cavity bigger. Your intercostal muscles between your ribs tightened up, too. This made your ...

While symptoms of Covid-19 often overlap with hMPV—such as fever, cough, and shortness of breath—Covid-19 is more likely to cause severe illness, including pneumonia and acute respiratory distress ...

Cases of flu, COVID and RSV remain high across the U.S., CDC data shows. Respiratory viruses are continuing to spread across the United States, sickening millions of Americans. Overall respiratory ...

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing critical needs in cardiovascular health. Under Rhiannon White's leadership ...

The European Commission’s approval of Gohibic for treating SARS-CoV-2-induced acute respiratory distress syndrome is a positive step, although its commercial impact remains uncertain due to ...